Anti-Helicobacter pylori activity of antimicrobial substances produced by lactic acid bacteria isolated from Baikkimchi

Journal of the Korean Society for Applied Biological Chemistry

Volumn 57, Issue 5, 2014, Pages 621-630

  Lim, Sung Mee ^a  

^a Tongmyong University   (South Korea)

Author keywords

adhesion; antimicrobial substance; Helicobacter pylori; lactic acid bacteria; urease

Indexed keywords

EID: 84909641691     PISSN: 17382203     EISSN: 2234344X     Source Type: Journal    
DOI: 10.1007/s13765-014-4198-6     Document Type: Article

References (46)

1. Adamsson I, Edlund C, and Nord CE. (2000) Microbial ecology and treatment of Helicobacter pyloriHelicobacter pylori infections: review. J Chemother12, 5–16.
2. Aiba Y, Suzuki N, Kabir AM, Takagi A, and Koga Y. (1998) Lactic acidmediated suppression of Helicobacter pylori of Lactobacillus salivarius as a probiotic in gnotobiotic murine model. Am J Gastroenterol93, 2097–101.
3. Andrzejewska E and Szkaradkiewicz A. (2007) Evaluation of the antagonistic effect of Lactobacillus acidophilus on clinical strains of Helicobacter pylori. Med Dosw Mikrobiol59, 59–64.
4. Bhatia SJ, Kochar N, Abraham P, Nair NG, and Mehta AP. (1989) Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol27, 2328–30.
5. Canducci F, Cremonini F, Armuzzi A, Di Caro S, Gabrielli M, Santarelli L, Nista E, Lupascu A, De Martini D, and Gasbarrini A. (2002) Probiotics and Helicobacter pylori eradication. Digest Liver Dis34, S81–3.
6. Coconnier MH, Lievin V, Bernet-Camard MF, Hudault S, and Servin AL. (1997) Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Ch41, 1046–52.
7. Coconnier MH, Lievin V, Hemery E, and Servin AL. (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol64, 4573–80.
8. De Bortoli N, Leonardi G, Ciancia E, Merlo A, Bellini M, Costa F, Mumolo MG, and Ricchiuti A. (2007) Helicobacter pylori eradication: a randomized, prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol102, 951–6.
9. De Vuyst L and Leroy F. (2007) Bacteriocins from lactic acid bacteria: production, purification, and food applications. J Mol Microbiol Biotechnol13, 194–9.
10. Dunn BE, Cohen H, and Blaser MJ. (1997) Helicobacter pylori. Clin Microbiol Rev10, 720–41.
11. El-Adawi H, El-Sheekh M, Khalil M, El-Deeb N, and Hussein M. (2013) Lactic acid bacterial extracts as anti-Helicobacter pylori: a molecular approach. Ir J Med Sci182, 439–52.
12. Felley C and Michetti P. (2003) Probiotics and Helicobacter pylori. Best Pract Res Cl Ga17, 785–91.
13. Gotteland M, Brunser O, and Cruchet S. (2006) Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther23, 1077–86.
14. Hamilton-Miller JM. (2003) The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents22, 360–6.
15. Holo H, Nilssen O, and Nes IF. (1991) Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. cremoris: Isolation and characterization of the protein and its gene. J Bacteriol173, 3879–87.
16. Jack RW, Tagg JR, and Ray B. (1995) Bacteriocins of gram-positive bacteria. Microbiol Mol Bol Rev59, 171–200.
17. Jung JY, Lee SH, and Jeon CO. (2014) Kimchi microflora: history, current status, and perspectives for industrial kimchi production. Appl Microbiol Biotechnol98, 2385–93.
18. Kang JH and Lee MS. (2005) In vitro inhibition of Helicobacter pylori by Enterococcus faecium GM-1. Can J Microbiol51, 629–36.
19. Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, and Song IS. (2008) The effects of probiotics on PPItriple therapy for Helicobacter pylori eradication. Helicobacter13, 261–8.
20. Kim TS, Hur JW, Yu MA, Cheigh CI, Kim KN, Hwang JK, and Pyun YR. (2003) Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot66, 3–12.
21. Lee HJ, Yoon HS, Ji YS, Kim HN, Park HJ, Lee JE, Shin HK, and Holzapfel W. (2011) Functional properties of Lactobacillus strains isolated from kimchi. Int J Food Microbiol145, 155–61.
22. Lesbros-Pantoflickova D, Corthesy-Theulaz I, and Blum AL. (2007) Helicobacter pylori and probiotics. J Nutr137, 812S–8S.
23. Lin WH, Lin CK, Sheu SJ, Hwang CF, Ye WT, Hwang WZ, and Tsen HY. (2009) Antagonistic activity of spent culture supernatants of lactic acid bacteria against Helicobacter pylori growth and infection in human gastric epithelial AGS cells. J Food Sci74, M225–30.
24. Lin WH, Wu CR, Fang TJ, Guo JT, Huang SY, Lee MS, and Yang HL. (2011) Anti-Helicobacter pylori activity of fermented milk with lactic acid bacteria. J Sci Food Agric91, 1424–31.
25. Lorca GL, Wadstrom T, Valdez GF, and Ljungh A. (2001) Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol42, 39–44.
26. Malfertheiner P, Mgraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, and Kuipers EJ. (2002) Current concepts in the management of Helicobacter pylori infection. Aliment Pharm Ther16, 167–80.
27. Maragkoudakis PA, Zoumpopoulou G, Christos M, Kalantzopoulos G, Pot B, and Tsakalidou E. (2006) Probiotic potential of Lactobacillus strains isolated from dairy products. Int Dairy J16, 189–99.
28. Martin NI, Hu H, Moake MM, Churey JJ, Whittal R, Worobo RW, and Vederas JC. (2003) Isolation, structural characterization, and properties of mattacin (polymyxin M), a cyclic peptide antibiotic produced by Paenibacillus kobensis M. J Biol Chem278, 13124–32.
29. Matsumoto S, Washizuka Y, Matsumoto Y, Tawara S, Ikeda F, Yokota Y, and Karita M. (1997) Appearance of metronidazole-resistant Helicobacter pylori strain in an infected ICR-mouse model and difference in eradication of metronidazole-resistant and-sensitive strains. Antimicrob ai]Agents Chemother41, 2602–5.
30. McGowan CC, Cover TL, and Blaser MJ. (1996) Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology110, 926–38.
31. Medouakh L, Abdeslam AA, and Bensoltane A. (2010) Antagonistic activity of Lactobacillus sp. against Helicobacter pylori. Int J Microbiol Res1, 80–6.
32. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, and Corthésy-Theulaz I. (1990) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion60, 203–9.
33. Midolo PD, Lambert JF, Hull R, Luo F, and Grayson ML. (1995) In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol79, 475–9.
34. Motta AS and Brandelli A. (2002) Characterization of an antibacterial peptide produced by Brevibacterium lines. J Appl Microbiol92, 63–71.
35. Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, and Ohori H. (2002) Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Mic32, 105–10.
36. Murosaki S, Muroyama K, Yamamoto Y, and Yoshikai Y. (2000) Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interjeukin-12 production in tumor-bearing mice. Cancer Immunol Immun49, 157–64.
37. 2-producing Lactobacillus gasseri isolated from the vaginal tract of cattle. Anim Reprod Sci96, 35–46.
38. Patel A, Shah N, and Prajapati JB. (2013) Clinical appliance of probiotics in the treatment of Helicobacter pylori infection-A brief review. J Microbiol Immunol Infect46, 1–9.
39. Piard JC, Muriana PM, Desmaze MJ, and Kiaenhammer TR. (1992) Purification and partial characterization of lacticin 481, a lanthioninecontaining bacteriocin produced by Lactobacillus lactis subsp. lactis CNRZ 481. Appl Environ Microbiol58, 279–84.
40. Rhee SJ, Lee JE, and Lee CH. (2011) Importance of lactic acid bacteria in ai]Asian fermented foods. Microb Cell Fact10, S5–18.
41. Ryan KA, Daly P, Li Y, Hooton C, and O’Toole PW. (2008) Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemoth61, 831–4.
42. Sgouras D, Maragkoudakis P, Petraki K, Martine-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, and Mentis A. (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strains Shirota. Appl Environ Microbiol70, 518–26.
43. Sullivan A and Nord CE. (2002) The place of probiotics in human intestinal infections. Int J Antimicrob Ag20, 313–9.
44. Tsai CC, Huang LF, Lin CC, and Tsen HY. (2004) Antagonistic activity against Helicobacter pylori infection in vitro by a strain of Enterococcus faecium TM39. Int J Food Microbiol96, 1–12.
45. Vitor JMB and Vale FF. (2011) Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS immunol Med Microbiol63, 153–64.
46. Yoon YH and Won BR. (2002) Antagonism against Helicobacter pylori and proteolysis of Lactobacillus helveticus CU631 and strain identification. Asian-Aust J Anim Sci15, 1057–65.